Related Experiment Video
Updated: May 13, 2026

Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
Published on: February 14, 2020
Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes
Abstract:
Non-enzymatic modification of proteins in hyperglycemia is a major proposed mechanism of diabetic complications. Specifically, advanced glycation end products (AGEs) derived from hyperglycemia-induced reactive carbonyl species (RCS) can have pathogenic consequences when they target functionally critical protein residues. Modification of a small number of these critical residues, often undetectable by the methodologies relying on measurements of total AGE levels, can cause significant functional damage. Therefore, detection of specific sites of protein damage in diabetes is central to understanding the molecular basis of diabetic complications and for identification of biomarkers which are mechanistically linked to the disease. The current paradigm of RCS-derived protein damage places a major focus on methylglyoxal (MGO), an intermediate of cellular glycolysis. We propose that glyoxal (GO) is a major contributor to extracellular matrix (ECM) damage in diabetes. Here, we review the current knowledge and provide new data about GO-derived site-specific ECM modification in experimental diabetes.
Insights
Advanced glycation end products (AGEs) from reactive carbonyl species (RCS) cause diabetic complications. This study highlights glyoxal (GO) as a key contributor to extracellular matrix (ECM) damage in diabetes.
Area of Science:
- Biochemistry
- Endocrinology
- Molecular Biology
Background:
- Hyperglycemia-induced non-enzymatic protein modification, forming advanced glycation end products (AGEs), is a key mechanism in diabetic complications.
- Reactive carbonyl species (RCS) are implicated in AGE formation, targeting critical protein residues and causing functional damage.
- Current research focuses on methylglyoxal (MGO), but other RCS like glyoxal (GO) may also significantly contribute to diabetic pathology.
Purpose of the Study:
- To investigate the role of glyoxal (GO) in extracellular matrix (ECM) modification in the context of diabetes.
- To provide site-specific data on GO-derived ECM damage.
- To advance the understanding of molecular mechanisms underlying diabetic complications.
Main Methods:
- Review of current knowledge on RCS-derived protein damage.
- Presentation of new data on glyoxal (GO)-derived site-specific ECM modification.
- Utilizing experimental models of diabetes.
Main Results:
- Glyoxal (GO) is proposed as a major contributor to extracellular matrix (ECM) damage in diabetes.
- Site-specific modifications of ECM proteins by GO were investigated.
- Data supports the pathogenic role of GO in diabetic complications.
Conclusions:
- Glyoxal (GO) plays a significant role in ECM damage in diabetes, complementing the known effects of MGO.
- Understanding site-specific protein damage is crucial for identifying biomarkers and therapeutic targets for diabetic complications.
- Further research into GO-mediated damage is warranted to elucidate the full molecular basis of diabetes.
More Related Videos
07:32Human Ex vivo Wound Model and Whole-Mount Staining Approach to Accurately Evaluate Skin Repair
Published on: February 17, 2021
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Proteoglycans
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Diabetic Neuropathy
Extracellular Matrix
Role of Matrix Metalloproteases in Degradation of ECM
A...